DUBLIN--(BUSINESS WIRE)--The "Drugs
for Rheumatoid Arthritis: Global Markets to 2022" report has
been added to ResearchAndMarkets.com's offering.
This research report categorizes the drugs for rheumatoid arthritis
market by type. Product type include disease modifying anti-rheumatic
drugs, non-steroidal anti-inflammatory drugs and corticosteroids.
Report
Includes:
- 95 data tables
- An overview of the global rheumatoid arthritis drugs market
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Identification of segments with high growth potential and their future applications
- Explanation of major drivers and regional dynamics of the market and current trends within the industry
Key Topics Covered:
1 Introduction
2 Summary and Highlights
3 Drugs for
Rheumatoid Arthritis Market Characteristics
4
Drugs for Rheumatoid Arthritis Market Size and Growth
- Historic Market Growth
- Drivers of the Market
- Restraints on the Market
- Forecast Market Growth
- Drivers of the Market
- Restraints on the Market
5 Drugs for Rheumatoid Arthritis Market Trends and Strategies
- Increasing Use of Technology
- 3D Printing Technologies
- Combo and Mono Therapy
- New Applications of NSAIDS
6 PESTLE Analysis
- Political
- Government Financial Support
- Uncertain Political Policies
- Economic
- Wealth
- Globalization
- Emerging Markets
- Social
- Ageing Global Population
- Sedentary Lifestyles
- Health Consciousness and Awareness
- Traditional Medicine Continues to Pose Threat to Market
- Technological
- 3D Printing Technologies
- Internet Penetration and Mobile Applications
- Legal
- Stringent Regulations and Long Approval Procedures
- Investment Regulations
- Patent Issues
- Government Intervention
- Environmental
7 Drugs for Rheumatoid Arthritis Market Segmentation
- Global Drugs for Rheumatoid Arthritis Market, By Segment
- Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
- Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Market Characteristics
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Market Characteristics
- Corticosteroids
- Market Characteristics
8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis
- Global Drugs for Rheumatoid Arthritis Market, By Region
- Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
- Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
- Global Drugs for Rheumatoid Arthritis Market, By Country
- Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
- Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors
- Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
- Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
10 Asia-Pacific Drugs for Rheumatoid Arthritis Market
11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis
12 Western Europe Drugs for Rheumatoid Arthritis Market
13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
14 Eastern Europe Drugs for Rheumatoid Arthritis Market
15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis
16 North America Drugs for Rheumatoid Arthritis Market
17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis18 South America Drugs for Rheumatoid Arthritis Market
19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis
20 Middle East Drugs for Rheumatoid Arthritis Market
21 Africa Drugs for Rheumatoid Arthritis Market
22 Drugs for Rheumatoid Arthritis Market Customer Information
- Frequency of Pain after Treatment
- Different Symptoms Experienced by Patients
- Impact of Rheumatoid Arthritis at Workplace
- Importance of Patient's Role in the Management of Rheumatoid Arthritis
- Capacity of Affordable Treatment
23 Drugs for Rheumatoid Arthritis Market Competitive Landscape
- Company Profiles
- Abbvie Inc.
- Amgen Inc.
- Bristol-Myers Squibb Company
- F. Hoffmann-La Roche AG
- Pfizer
24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market
- Pfizer Acquired Hospira
- Concordia Healthcare Acquired Covis Pharma Commercial Assets
- Bristol-Myers Squibb Acquired Padlock Therapeutics
- Alvotech Acquired Baliopharm
- Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche
25 Appendix
Companies Mentioned
- AbbVie Inc.
- Amgen Inc.
-
Biogen
- Merck & Co.
- Bristol-Myers Squibb
- Hoffmann-La Roche
- Johnson & Johnson
- Mitsubishi Tanabe Pharma Corporation
- Pfizer
- UCB S.A.
For more information about this report visit https://www.researchandmarkets.com/research/rsdttr/global_rheumatoid?w=4
